key: cord-0967919-ls0x4fr2
authors: Greenwald, H. D.; Kennedy, L. C.; Hinkle, A.; Whitney, O. N.; Fan, V. B.; Crits-Christoph, A.; Harris-Lovett, S.; Flamholz, A. I.; Al-Shayeb, B.; Liao, L. D.; Beyers, M.; Brown, D.; Chakrabarti, A. R.; Dow, J.; Frost, D.; Koekemoer, M.; Lynch, C.; Sarkar, P.; White, E.; Kantor, R.; Nelson, K. L.
title: Interpretation of temporal and spatial trends of SARS-CoV-2 RNA in San Francisco Bay Area wastewater
date: 2021-05-07
journal: nan
DOI: 10.1101/2021.05.04.21256418
sha: 30538cdb7362bd16b673ce26ae91df39f21ce296
doc_id: 967919
cord_uid: ls0x4fr2

Wastewater surveillance for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can be integrated with COVID-19 case data to inform timely pandemic response. However, more research is needed to apply and develop systematic methods to interpret the true SARS-CoV-2 signal from noise introduced in wastewater samples (e.g., from sewer conditions, sampling and extraction methods, etc.). In this study, raw wastewater was collected weekly from five sewersheds and one residential facility, and wastewater SARS-CoV-2 concentrations were compared to geocoded COVID-19 clinical testing data. SARS-CoV-2 was reliably detected (95% positivity) in frozen wastewater samples when reported daily new COVID-19 cases were 2.4 or more per 100,000 people. To adjust for variation in sample fecal content, crAssphage, pepper mild mottle virus, Bacteroides ribosomal RNA (rRNA), and human 18S rRNA were evaluated as normalization biomarkers, and crAssphage displayed the least spatial and temporal variability. Both unnormalized SARS-CoV-2 RNA signal and signal normalized to crAssphage had positive and significant correlation with clinical testing data (Kendall's Tau-b=0.43 and 0.38, respectively). Locational dependencies and the date associated with testing data impacted the lead time of wastewater for clinical trends, and no lead time was observed when the sample collection date (versus the result date) was used for both wastewater and clinical testing data. This study supports that trends in wastewater surveillance data reflect trends in COVID-19 disease occurrence and presents approaches that could be applied to make wastewater signal more interpretable and comparable across studies.

Increasing hospitalizations and limited diagnostic testing capacity early in the coronavirus disease 70 each of these normalization biomarkers has been assessed independently, they have not all been 121 compared within the same study. 122 123 In addition to normalizing the target signal, smoothing procedures can assist in discerning 124 temporal trends in SARS-CoV-2 occurrence. While seven-day moving averages have been widely 125 used for assessing clinical data trends in real-time ("Track Testing Trends," n.d.), wastewater 126 sampling is often performed only 1-3 times per week. Therefore, smoothing techniques are 127 needed that can be applied to data with lower sampling frequency that minimize loss of temporal 128 resolution, such as locally weighted scatterplot smoothing (Lowess) ( cases for which SARS-CoV-2 RNA is reliably detected in wastewater (WBE case detection limit). 139

The WBE case detection limit is dependent on the methods used to extract genetic material as 140 well as the extent of local clinical testing and may require sewershed-specific assessment. 141

However, a systematic approach to estimate this value across studies can aid interpretation of 142 nondetects and elucidate the number of COVID-19 cases per capita above which COVID-19 WBE 143 will be a reliable public health surveillance strategy. In a recent study (Wu et al., 2021) , a WBE 144 case detection limit was estimated using a dataset with 1,687 samples, which was large enough 145 to include repeated wastewater measurements at low case numbers. With fewer data points, 146 researchers have estimated this value observationally by reporting the number of cases they were 147 able to detect or quantify Medema et al., 2020) . 148

The goal of this research was to develop and assess approaches for COVID-19 WBE data 150 validation and interpretation. Specific objectives were to: (i) evaluate normalization biomarkers 151 (crAssphage, pepper mild mottle virus, Bacteroides rRNA, and human 18S rRNA) for adjusting 152 SARS-CoV-2 RNA signal to account for variable wastewater fecal content; (ii) assess SARS-153

CoV-2 wastewater testing as a complement to clinical testing for public health surveillance by 154 determining the correlation between these two methods; (iii) determine whether wastewater 155 trends lead clinical trends and could provide early warning of COVID-19 outbreaks; (iv) evaluate 156 a systematic method for trendline smoothing; (v) develop a systematic method for estimating a 157 WBE case detection limit; and (vi) apply these methods to interpret spatial and temporal trends 158 in COVID-19 occurrence based on wastewater and clinical testing data. We analyzed a sample 159 set from six locations in the San Francisco Bay Area containing 5 months of weekly raw 160 wastewater samples paired with geocoded clinical data. 161 162

Six locations in the San Francisco Bay area were sampled (referred to throughout as locations A, 164 S, N, K, Q, and E). Raw wastewater was collected weekly and archived from April to September 165 2020, and biological replicates were processed for some locations as indicated in Table 1 . CoV-2 and normalization biomarkers (crAssphage, PMMoV, Bacteroides rRNA, and 18S rRNA) 167

were measured in wastewater samples via RT-qPCR. Associated physicochemical data were 168 collected by wastewater utilities, and associated geocoded clinical COVID-19 data were collected 169 by public health departments (Table 1) . 170 171 172 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint 2.1 Wastewater sample collection and physicochemical data 173 24-hour time-weighted composite samples of raw wastewater were collected using Teledyne 174 ISCO autosamplers. Some samples were collected and processed in biological replicate (i.e., 175 wastewater subsamples were aliquoted from the same composite sample but independently 176 extracted). After collection, all samples were transported to the lab on ice, stored at either -20°C 177 or -80°C, and then thawed at 4°C for 36-48 hours before extractions. Wastewater data was not 178 individually identifiable; therefore, no IRB was needed. More information on location-specific data 179 collection and wastewater sampling, transport, storage, and biological replicates is provided in 180 Table S1), which is negligible when compared to the variation displayed by normalization 187 biomarkers over time (15%-244%; Figure 1 ). Mean flow rates were provided by the wastewater 188 utility for locations A, N, and S and were calculated from daily flow rates for locations K, E, and Q 189 ( Raw Cq values that did not amplify or that amplified below the limit of detection were substituted 249 with the Cq value corresponding to half the limit of detection (for N1) or half the lowest point of 250 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint the master standard curve (for all other assays) (Table S6) , and then outliers were assessed 251 using a two-sided Grubbs test (alpha=0.05). The N1 qPCR limit of detection (LoD) was calculated 252 by analyzing all RNA standard curves from the study as well as four additional extended triplicate 253 standard curves. The N1 LoD was set at 5 gene copies per reaction, at which point 67% of 254 technical replicates were positive (Table S8) . Further details on the data processing pipeline are 255 provided in SI Section D. 256 257

To our knowledge, there is no standard methodology for assessing PCR inhibition in raw 259 wastewater samples. We combined two approaches to assess PCR inhibition in raw wastewater amplification control can easily be included in every sample, but cannot detect assay-specific 263 inhibition (Schrader et al., 2012) . Serial dilution consumes more resources and risks diluting the 264 target signal below the detection limit, but it more accurately tests the target itself and allows 265 selection of a dilution value that best reduces the impacts of inhibition. Thus, we used the 266 VetMAX™ Xeno™ Internal Positive Control (ThermoFisher Scientific) as a screening tool to select 267 samples for further testing with serial dilution. 268 269 For all samples, Xeno RNA was spiked into the reaction mix (Table S2) , and NTCs were used as 270 an inhibition-free baseline to compare each sample on that plate. Ten samples showed >2 Cq 271 deviation from the baseline and were selected for further inhibition testing (Staley et al., 2012) . A 272 dilution series (1x, 2x, 5x, 10x) was performed on these samples, and the duplexed N1 and Xeno 273 assay was repeated. A dilution was chosen by comparing SARS-CoV-2 N1 signal in each dilution 274 to theoretical expectations (based on theoretical doubling per PCR cycle). If diluting the sample 275 led to a 1 Cq difference between actual and expected change in Cq, then the sample at the base 276 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) For N1 normalization to biomarkers, N1 (gene copies per liter, gc/L) was divided by the 288 normalization biomarker concentration (gc/L). To calculate flow-scaled biomarker load 289 (gc/person/day), target concentration (gc/L) was multiplied by mean flow for the sampling location 290 (MGD) and a unit conversion factor (liter per million gallons) and then divided by population. Daily 291 flow rate data were not available for S, N, and A (locations upstream of a treatment facility) (Table  292 S1), so mean dry weather flow rates (and population) were used to scale data when comparing 293 across locations. We expect that the mean flow rate likely approximates the daily flow rate 294 throughout the study period, but this may not hold true in different locations and seasons. 295 296 For comparisons of biomarker concentrations and variation (Figure 1) , a Kruskall-Wallis test 297 (SciPy v1.4.1) was performed, followed by pairwise Dunn's tests (scikit-posthocs v0.6.6) to 298 determine statistical differences. Rank correlations between wastewater and case data ( Figure  299 2) were calculated as Kendall's Tau-b coefficients ( ; SciPy v1.4.1), a method adapted for left-300 censored data (i.e., datasets with data below a lower limit of detection) (Wood et al., 2011) 301 because 22% of the data are below the N1 LoD. Correlations were classified as low ( < 0.3), 302 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint moderate (0.3 < < 0.5), or high ( > 0.5). Coefficients of variation (CV) were calculated as the 303 arithmetic standard deviation divided by the mean, while geometric coefficient of variation (gCV) 304 was calculated as the geometric standard deviation minus one. 305 306 2.6.2 Assessment of WBE case detection limit 307

The WBE case detection limit was estimated as follows. The paired wastewater and case data 308 for all sewersheds were combined and sorted from highest to lowest case counts. For each case 309 count, all technical replicates in the wastewater data at and above that point were tallied to 310 determine the cumulative percentage of replicates that amplified in RT-qPCR. Equation 1 was 311 used to fit a logistic function (Kyurkchiev and Markov, 2016) For wastewater data, any smoothed trendline displayed in a figure was determined using a fitted 324 local regression (Lowess; statsmodels v0.10.2) with bandwidth parameter (α, the fraction of the 325 dataset used for smoothing), set as previously shown (Jacoby, 2000) (Figures 3 and S2-S5) . 326

Lowess trends of SARS-CoV-2 N1 signal were also visualized as heatmaps to aid in discerning 327 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. Raw wastewater was collected weekly from April to September 2020 at six locations (Table 1) . 332

The resulting dataset includes 91 samples (155 including biological replicates), analyzed for 333 SARS-CoV-2 and four potential normalization biomarkers (crAssphage, PMMoV, Bacteroides 334 rRNA, and human 18S rRNA) and paired with geocoded clinical testing data. This dataset was 335 generated from the San Francisco Bay Area in separate sanitary sewer systems during a period 336 with minimal rainfall (see Methods), which naturally controlled for variability in wastewater strength 337 due to precipitation. Thus, we expected the concentrations of the measured normalization 338 biomarkers to be relatively stable. Additionally, geocoded clinical testing data included a range of 339 per capita COVID-19 case rates that varied by location. (Table S10 ) in all 347 samples tested, except for 18S rRNA, which was inconsistently quantifiable ( Figure S8 ). Flow 348 rates and chemical wastewater parameters (TSS, BOD, COD, cBOD) were not consistently 349 measured by utilities (Table S1) ; thus, robust comparisons of physicochemical biomarkers could 350 not be made. In the absence of daily flow rate data, we used mean flow rate to scale wastewater 351 biomarker concentrations by per capita wastewater flow for each sewershed to account for 352 differences across sewersheds (Figure 1 ). Mean per capita flow rates were similar for all locations 353 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint except Q (a facility; Table 1) are several limitations to assessing correlation between clinical testing data and wastewater data. 390

First, clinical testing data do not necessarily represent true incidence because of biases 391 associated with testing. Even if clinical and wastewater testing data correspond to the same date, 392 fecal shedding could peak before symptom onset, which would impact the correlation unless the 393 correct time offset is applied to reflect this discrepancy (Hoffmann and Alsing, 2021 Figure 2) ; however, normalization 407 did not strengthen the correlation compared to unnormalized signal. Conversely, PMMoV 408 normalization produced only a weak correlation of 0.18 (p < 0.05) (Figure 2) . Analysis was 409 performed with and without samples that were below the limit of detection and produced similar 410 results ( Table S11) . Of the normalization biomarkers tested, crAssphage had the lowest variability 411 and also maintained significant and moderate correlation with clinical testing data, so we included 412 it in subsequent analyses alongside unnormalized concentrations. 413

The correlation analysis was repeated with data separated by location to determine whether 415 locational dependencies affect the relationship between wastewater and clinical testing data as 416 well as the performance of normalization strategies. Locations with at least 75% of data above 417 the N1 qPCR LoD (Locations K, N, and S; Table S12) were included in this analysis. Only location 418 K had significant correlations with clinical testing data, both with and without crAssphage 419 normalization ( unnormalized=0.5 and crAssphage=0.43, p<0.05; Figure S10 ). This finding suggests 420 locational dependencies (e.g., differences in extent of clinical testing, sewer system residence 421 times, etc.) affect the correlation with clinical testing data. Additionally, the location-specific 422 analysis was repeated including only samples with detectable SARS-CoV-2 N1 signal, and the 423 results were no longer statistically significant ( Figure S10 ). This finding is likely influenced by both 424 the limited sample size and values below the N1 qPCR LoD that affect rank correlations. 425 426 In addition to the limitations in clinical testing data mentioned at the beginning of this section, 427 there are several explanations for why wastewater signal at locations S, N and K did not 428 significantly correlate with clinical testing data after removing values below the LoD: (i) the daily 429 per capita cases in the population were at or below the WBE case detection limit of the wastewater 430 data; (ii) the daily per capita cases that were masked by public health departments for patient 431 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint privacy imparied the rank correlation analysis by left-censoring the clinical testing data; (iii) the 432 wastewater signal did not vary enough over the time of sampling to establish rank. The possibility 433 that the wastewater signal leads the clinical testing data was subsequently tested for locations K, 434 N, and S (i.e., correlations were examined for zero-, one-, and two-week offsets); however, 435 location K was the only location with significant correlation between wastewater and clinical 436 testing data for any lead time tested (Figure S10) . To assess the impact of crAssphage normalization on SARS-CoV-2 N1 temporal trends, we 506 compared unnormalized and crAssphage-normalized Lowess trendlines (Figure 4) . We found 507 that crAssphage-normalized trends were similar to unnormalized trends for three of the locations 508 (K, N, and A) but had differences in overall trend for locations Q (Figure 5 ) and S (Figure S12) . 509 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint Discrepancies are concerning because they could have implications for pandemic response. We 510 note that the trend in location K, for which biological replicates were processed routinely, was the 511 least impacted by bandwidth or normalization (Figures S2 and S12) . Larger datasets with more 512 frequent sampling and processing of biological replicates, would give single points less influence 513 over the trend. 514 515 Relative spatio-temporal trends in clinical and wastewater testing results were compared across 516 sampling sites (Figures 4, S6, and S7) . (Figures 4 and S6) and higher SARS-CoV-2 signal in wastewater 525 at location N (relative to other locations) than represented by the clinical data (Figures 4 and S7) . 526 527 3.6 The WBE case detection limit was estimated to be 2.4 COVID-19 cases per 100,000 528 people 529

Quantifying the minimum per capita new COVID-19 cases in a sewershed at which there is 530 reliable detection of SARS-CoV-2 N1 in wastewater (WBE case detection limit) is important for 531 gauging the utility of COVID-19 WBE when the true incidence is low. This WBE case detection 532 limit depends on the detection limit of the wastewater measurement (i.e., the methods used to 533 store, concentrate, extract, and measure SARS-CoV-2 RNA in wastewater) and the accuracy of 534 the clinical testing data available. To estimate the WBE case detection limit in a way that is 535 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. replicates amplified via RT-qPCR for N1 (Figure 6) . Other researchers have used non-cumulative 540 methods to estimate the WBE case detection limit by calculating the percent of amplified 541 wastewater replicates for each case value (Wu et al., 2021) . This method requires repeated 542 wastewater measurements associated with each possible clinical case value or range of case 543 values (i.e., bins). Otherwise, the percent of amplified technical replicates is limited, as was the 544 case in this study where only one biological replicate was often associated with each case number 545 (Figure S13 A) . Ideally, all data would be unmasked when applying this method. To verify that 546 the masked clinical data did not affect the estimated WBE case detection limit, the process was 547 repeated with masked values, and the estimate was similar (2.2 cases in 100,000 people; Figure  548 Based on the contributing population of each sewershed in this study, the WBE case detection 553 limit translates to 11.6 cases for K, 11.3 cases for S, 3.3 cases for N, 2.0 cases for A, and 0.1 554 cases for Q. Therefore, at location Q, one case should be reliably detected based on results from 555 this analysis, which could be tested observationally because only one new case was detected by 556 clinical testing after August 12 th (Figure 5) with the test results provided on 8/26. When 557 wastewater sampling was completed on 8/25 and 9/1, a weak positive signal was observed (one 558 technical replicate amplified). These results support that wastewater testing can detect clinical 559 cases in facilities with a single case; however, to capture a strong positive signal from one case 560 at a facility, higher frequency sampling is recommended. A possible explanation for why a single 561 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint case may still go undetected, despite being above the WBE case detection limit, is that 562 wastewater surveillance relies on the autosampler aliquots capturing the feces from each infected 563 individual, which becomes less likely when there are fewer infected individuals and wastewater 564 has less mixing prior to the sampling location. These results are promising for the application of 565 WBE in facilities, where it is highly resource-intensive to conduct routine clinical surveillance 566 testing frequently enough to detect a single case in time to enact preventative measures. More 567 work is needed applying WBE for SARS-CoV-2 across a broader set of facilities. 568 Discrepancies between wastewater testing data and clinical testing data trends from early in the 611 time series at location N (April-July 2020; Figure S12 ) could be used to infer clinical undertesting, 612 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. ;

(e.g., skilled nursing facilities, homeless shelters, etc.), especially where clinical testing is not 638 available or routine. 639 (Table S10) . Similarly, no values were found in the 657 literature for 18S rRNA concentrations in raw wastewater (Table S10) . In this study, 18S rRNA 658 signal displayed a wide range in concentrations and consistently amplified in negative extraction 659 controls. Furthermore, 18S rRNA was less stable in wastewater than SARS-CoV-2 RNA and 660 nonenveloped viruses (e.g., crAssphage and PMMoV), which is consistent with previous studies 661 (Whitney et al., 2021; Wurtzer et al., 2020) . Therefore, we do not recommend 18S rRNA use as 662 a normalization biomarker. In comparison to all of the biomarkers tested, crAssphage had low 663 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint spatial variability (i.e., the fewest locations with statistically different loads; Figure 1 ) and temporal 664 variability (gCV=59%; Figure 1) Although a standardized approach would facilitate comparisons across studies, the ideal 671 normalization strategy may be situationally dependent. For example, in this study, for some 672 locations, crAssphage-normalization did not have a major impact on general spatio-temporal 673 trends and did not improve correlations to clinical data compared to unnormalized signal, likely 674 due to the lack of precipitation or changes in flow throughout the study period. Several factors 675 should be considered when deciding whether to normalize to a biomarker or report unnormalized 676 concentrations. First, adding another assay introduces additional analytical variation that could 677 outweigh the benefits of biomarker normalization in some settings (Feng et al., 2021 ). An 678 additional consideration is ensuring methods compatibility with the WBE target and normalization 679 biomarker. Ideally, normalization to an endogenous biomarker would account for losses in target 680 signal during residence time in sewers, sample storage, and laboratory processing, but the ideal 681 biomarker for fecal content may not be the best surrogate for the target of interest. For example, 682 crAssphage is not expected to be a good surrogate for SARS-CoV-2 stability, partitioning, and 683 extraction (Ye et al., 2016) , and as a DNA virus, crAssphage may be incompatible with some 684 extraction methods used for SARS-CoV-2 RNA. Other controls (e.g., endogenous biomarkers, 685 recovery controls) and modeling may be applied to improve measurement accuracy and translate 686 results across labs and methods, although there are challenges associated with these corrections 687 . Degradation modeling with target-specific decay constants (Ahmed et al., 688

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint 2020a) and sewershed-specific parameters could assist in correcting for degradation or 689 determining sample integrity, but no comprehensive approach for this correction exists. 690 691

In general, public health decisions are based on temporal trends in disease burden, not individual 693 data points, but trends in wastewater and clinical data can be difficult to visually distinguish, 694 especially when available resources constrain sampling frequencies. Applying Lowess to 695 wastewater data, we found that the value of one parameter could influence the trend visualization 696 such that the same dataset could lead to different public health responses (Figures 3 and S5) . 

In addition to data smoothing, we developed an approach for identifying a WBE case detection 707 limit that can be applied systematically to studies using PCR-based methods. We applied this 708 analysis to SARS-CoV-2 N1 signal in wastewater and found that the daily new clinical cases at 709 which wastewater surveillance could reliably detect clinically diagnosed COVID-19 cases in the 710 contributing population was estimated at 2.4 cases per 100,000 people. There are multiple 711 limitations to this analysis because wastewater detection depends on factors other than incidence, 712 such as sampling methods (e.g., frequency of sampling aliquots), which can influence the 713 probability of capturing shed viral particles from an infected individual. Additionally, the estimate 714 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. • The COVID-19 outbreak at San Quentin prison (location Q) corresponded to a measured 734 N1 concentration that was higher than any sewershed tested (4.89 x 10 3 gene copies/mL). 735

• The wastewater-based epidemiology case detection limit using the 4S RNA extraction 736 method on frozen samples was estimated to be 2.4 COVID-19 cases in 100,000 people. 737

• Lead time in wastewater over clinical testing varied from 0 to 3 weeks depending on the 738 location, biomarker normalization, and testing turnaround time. 739

• Systematic approaches for determining a WBE case detection limit, biomarker 740 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint included in the SI (Figure S8) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 7, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is included in the SI (Figures S6 and S7 ) and visualization of sewersheds by location can be 865 found in Figure S12 . 866 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint and clinical data at location Q from 868

June to September 2020, where 869 symbols indicate how many technical 870

replicates amplified during qPCR. 871

Wastewater data : (top) unnormalized 872

and (middle) crAssphage-normalized 873 SARS-CoV-2 N1 signal in wastewater, 874

where the horizontal dashed line 875

indicates the limit of detection, and 876

trendlines are the most optimal Lowess 877 trendline ( Figure S4) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. wastewater technical replicates was calculated by ranking the moving averages of daily per 903 capita cases (x-axis) from highest to lowest and calculating the fraction of qPCR replicates that 904 amplified cumulatively (y-axis) for each value of x. The dashed line represents the daily new 905 cases per capita value above which 95% of wastewater technical replicates amplified (2.4 cases 906 in 100,000 people). 907 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 7, 2021. ; https://doi.org/10.1101/2021.05.04.21256418 doi: medRxiv preprint

Selection bias 978 [WWW Document

CDCR Population COVID-19 Tracking

SARS-CoV-2 Community Transmission disproportionately 987 affects Latinx population during Shelter-in-Place in San Francisco

Towards 990 finding a population biomarker for wastewater epidemiology studies

Wastewater-based 994 epidemiology biomarkers: Past, present and future

998 Validation and testing of a method for detection of SARS-CoV-2 RNA in healthy human 999 stool

Covid 19 Wastewater Epidemiology. Bay Area

Catching a resurgence: 1005 Increase in SARS-CoV-2 viral RNA identified in wastewater 48 h before COVID-19 1006 clinical tests and 96 h before hospitalizations

Quantitative analysis of SARS-1011

CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and 1012 prevalence

Global phylogeography and ancient 1032 evolution of the widespread human gut virus crAssphage

Evaluation of sampling frequency and normalization of SARS-1036

CoV-2 wastewater concentrations for capturing COVID-19 burdens in the community

Early-pandemic wastewater 1039 surveillance of SARS-CoV-2 in Southern Nevada: Methodology, occurrence, and 1040 incidence/prevalence considerations

COVID-19 surveillance in Southeastern Virginia using 1049 wastewater-based epidemiology

SARS-CoV-2 in wastewater settled solids is associated with COVID-19 cases in a 1054 large urban sewershed

Quantification of SARS-CoV-2 and cross-assembly phage 1057 (crAssphage) from wastewater to monitor coronavirus transmission within communities. 1058 medRxiv

One-Step RT-qPCR for SARS-CoV-2 Wastewater Surveillance: N1

Collider bias undermines our understanding of COVID-19 disease risk and 1065 severity

Modeling wastewater temperature and attenuation of sewage-1067 borne biomarkers globally

Computational analysis of SARS-CoV-2/COVID-19 1070 surveillance by wastewater-based epidemiology locally and globally: Feasibility, 1071 economy, opportunities and challenges

Potential Sensitivity of Wastewater Monitoring for SARS-CoV-2: 1074 Comparison with Norovirus Cases

Faecal shedding models for SARS-CoV-2 RNA amongst 1077 hospitalised patients and implications for wastewater-based epidemiology

Loess: a nonparametric, graphical tool for depicting relationships between 1080 variables

Challenges in Measuring the 1082 Recovery of SARS-CoV-2 from Wastewater

Distribution of 1085 Human-Specific Bacteroidales and Fecal Indicator Bacteria in an Urban Watershed 1086 Impacted by Sewage Pollution, Determined Using RNA-and DNA-Based Quantitative 1087 PCR Assays

On the Hausdorff distance between the Heaviside step 1089 function and Verhulst logistic function

Analysis of viral 1093 load in different specimen types and serum antibody levels of COVID-19 patients

Wastewater Surveillance for Public Health Action: Connecting Perspectives From 1099

Wastewater Researchers and Public Health Officials During a Global Pandemic

Evaluation of sampling frequency and normalization of SARS-CoV-1103 2 wastewater concentrations for capturing COVID-19 burdens in the community. 1104 medRxiv

Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in 1107 the Early Stage of the Epidemic in The Netherlands

Racial/ethnic disparities in COVID-19 disease burden & mortality 1111 among emergency department patients in a safety net health system

COVID-19 and the 1114 Correctional Environment: The American Prison as a Focal Point for Public Health

Letter to the Editor: Wastewater-Based 1117 Epidemiology Can Overcome Representativeness and Stigma Issues Related to COVID-1118 19

Temporal Detection and Phylogenetic 1121 Assessment of SARS-CoV-2 in Municipal Wastewater

SPUD: A quantitative PCR assay 1124 for the detection of inhibitors in nucleic acid preparations

Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients 1129 With Coronavirus Disease 2019: A Systematic Review and Meta-analysis

Measurement of SARS-CoV-2 RNA in wastewater tracks community 1134 infection dynamics

Detection of Fecal Bacteria and Source Tracking Identifiers 1138 in Environmental Waters Using rRNA-Based RT-qPCR and rDNA-Based qPCR Assays

Making waves: Wastewater-based epidemiology for COVID-19 -1142 approaches and challenges for surveillance and prediction

1145 Metropolitan wastewater analysis for COVID-19 epidemiological surveillance

1148 SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence 1149 area

PCR inhibitors -occurrence, 1151 properties and removal

Quantitative PCR for Detection and 1155 Enumeration of Genetic Markers of Bovine Fecal Pollution

Future perspectives of wastewater-based epidemiology: 1158 Monitoring infectious disease spread and resistance to the community level

Source code for statsmodels module

Quantitative 1166

Wastewater Analysis of SARS-CoV-2 as a Predictive Metric of Positivity Rate for a 1172 Major Metropolis

Performance of Two Quantitative 1174 PCR Methods for Microbial Source Tracking of Human Sewage and Implications for 1175

Microbial Risk Assessment in Recreational Waters

Pepper mild mottle virus: Agricultural menace 1178 turned effective tool for microbial water quality monitoring and assessing (waste)water 1179 treatment technologies

Johns Hopkins Coronavirus Resource Center

Highly predictive regression model of active cases of 1185 COVID-19 in a population by screening wastewater viral load

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

V.4 -Direct wastewater RNA capture and purification via the Sewage, Salt, 1192 Silica and SARS-CoV-2 (4S) method

Sewage

An Economical Kit-Free Method for Direct Capture of 1196 SARS-CoV-2 RNA from Wastewater

Co-quantification of crAssphage increases 1200 confidence in wastewater-based epidemiology for SARS-CoV-2

Limit of detection values in data analysis: 1203 Do they matter?

Wastewater Surveillance of SARS-CoV-2 across 40 U.S. states. medRxiv

SARS-CoV-2 Titers in Wastewater Are 1213 Higher than Expected from Clinically Confirmed Cases. mSystems 5

Several forms of SARS-CoV-1217 2 RNA can be detected in wastewaters : implication for wastewater-based epidemiology 1218 and risk assessment

Wastewater-Based Epidemiology for Early Detection of Viral 1220 Outbreaks

Survivability, Partitioning, and 1224 Recovery of Enveloped Viruses in Untreated Municipal Wastewater

Wastewater-based epidemiology-1227 surveillance and early detection of waterborne pathogens with a focus on

Cocaine in surface waters: a new evidence-based tool to monitor community drug 1232 abuse

Estimating Community Drug Abuse by Wastewater Analysis. Environ. Health Perspect